NR2F6 and neoplasm: We also evaluated the prognostic value of NR2F6 expression in patient subgroups stratified by age, SCC antigen, HPV infection, tumor size, differentiation grade, FIGO stage, pelvic LNM (PLNM), radiation, chemotherapy, concurrent chemotherapy and radiotherapy, surgical margin properties, lymphovascular space involvement, myometrium invasion, and parauterine organ infiltration.